RxDoctor Payments Data

Jamie White

Nurse Practitioner · Bristol, TNNPI 1285110759

Payments from drug & device makers

$2,697in general payments, 2019–2025

Across 148 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$365
  • Novo Nordisk$282
  • Corium, LLC$281
  • AbbVie$281
  • Amgen$201
  • Pfizer$198
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,697100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,697 in reported general payments places this provider in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol39$26,263
JardianceEmpagliflozin23$15,964
Doxycycline Hyclate80$702
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst50$555
Buspirone Hcl46$520
Baclofen13$466
Levothyroxine Sodium101$452
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav53$433
Memantine Hcl ErMemantine Hcl13$426
Azelastine Hcl16$406
Escitalopram Oxalate56$355
Memantine Hcl54$322
Albuterol Sulfate HfaAlbuterol Sulfate12$291
Nystatin23$274
Atorvastatin Calcium82$272

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$365$26,26339 claims
Boehringer IngelheimJardiance$71$15,96423 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Bristol

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →